MYRIAD GENETICS, INC. Deferred Revenue Recognized
MYRIAD GENETICS, INC. (MYGN) reported Deferred Revenue Recognized of $2.30 million for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2020-11-09
- MYRIAD GENETICS, INC. contract with customer, liability, revenue recognized for the quarter ending 2020-09-30 was $2.30M, a 475.00% increase year-over-year.
- MYRIAD GENETICS, INC. contract with customer, liability, revenue recognized for the quarter ending 2019-09-30 was $400.00K, a 76.47% decline year-over-year.
- MYRIAD GENETICS, INC. contract with customer, liability, revenue recognized for the quarter ending 2018-09-30 was $1.70M, a 71.19% decline year-over-year.
- MYRIAD GENETICS, INC. contract with customer, liability, revenue recognized for the quarter ending 2017-09-30 was $5.90M.
- MYRIAD GENETICS, INC. contract with customer, liability, revenue recognized for fiscal 2020 was $7.20M, a 8.86% decline from fiscal 2019.
- MYRIAD GENETICS, INC. contract with customer, liability, revenue recognized for fiscal 2019 was $7.90M, a 43.57% decline from fiscal 2018.
- MYRIAD GENETICS, INC. contract with customer, liability, revenue recognized for fiscal 2018 was $14.00M.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2020-09-30 | $2.30M 10-Q · filed 2020-11-09 | |||
| 2020-06-30 | $7.20M 10-K · filed 2020-08-13 | |||
| 2020-03-31 | $2.40M 10-Q · filed 2020-05-06 | |||
| 2019-12-31 | $1.10M 10-Q · filed 2020-02-07 | |||
| 2019-09-30 | $400.00K 10-Q · filed 2020-11-09 | |||
| 2019-06-30 | $7.90M 10-K · filed 2020-08-13 | |||
| 2019-03-31 | $5.90M 10-Q · filed 2020-05-06 | |||
| 2018-12-31 | $2.60M 10-Q · filed 2020-02-07 | |||
| 2018-09-30 | $1.70M 10-Q · filed 2019-11-06 | |||
| 2018-06-30 | $14.00M 10-K · filed 2019-08-13 | |||
| 2018-03-31 | $13.80M 10-Q · filed 2019-05-08 | |||
| 2017-12-31 | $10.30M 10-Q · filed 2019-02-06 | |||
| 2017-09-30 | $5.90M 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |